FTSE 100

Key insight

The FTSE 100 is navigating a classic sector rotation story: BoE easing expectations are lifting rate-sensitive housebuilders and domestic financials, while falling oil prices from US-Iran diplomatic talks and an AstraZeneca M&A overhang are suppressing the index's heavyweight energy and pharma constituents — the net result is range-bound churn near all-time highs around 10,875.

The FTSE 100 holds above the key 10,800 psychological support and its 50-day MA (~10,720), buoyed by a strong July (+3.5–4.5%), BoE rate-cut expectations, and housebuilder/financials rotation — even as energy and pharma drag on AstraZeneca/BP/Shell weakness today.

Main risk

AstraZeneca BMS Merger Speculation + Energy Sector Drag

AstraZeneca (-6%) and Shell/BP (-1% to -2%) together represent over 12% of FTSE 100 weighting; sustained weakness in these heavyweights could cap any broader index rally above 11,000 resistance.